Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New laboratory to boost Japanese biotech prospects:

This article was originally published in Clinica

Executive Summary

Japan is building a developmental biology laboratory which will focus on regenerative medical technologies such as cloning and embryonic stem cell research. The RIKEN centre for developmental biology will be based in the city of Kobe and will receive a budget of $45 million. Its funding, however, is only guaranteed for three years, after which the Japanese government will evaluate its progress in order to determine how much additional funding it requires. The laboratory is also linked to a nearby hospital which is capable of carrying out clinical trials and has a mechanism to set up spin-off companies. It was founded as part of Japan's Million Programme, which allotted $900 million of funding for scientific initiatives. Japan is hoping the centre will propel its biotech capabilities ahead of countries such as the USA which are still struggling with ethical debate on the subject.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065094

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel